Lauren Gima, M.S., CGC

(877) 460-4673
Lauren Gima, M.S., CGC
Senior Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research
Clinical Expertise
  • Clinical Cancer Genetics
  • Hereditary Cancers
Research Area
  • Cancer Genetics

Lauren Gima, M.S., CGC, is a licensed and board-certified genetic counselor specializing in clinical cancer genomics. She earned her M.S. degree in genetic counseling from Northwestern University and B.S. degree in human biology with a minor in psychology from University of California San Diego. 

Gima joined City of Hope's Division of Clinical Cancer Genomics in 2017, previously working in general biology and immunology research at the University of California San Diego, before becoming a genetic counselor. 

Her primary clinical responsibilities include providing cancer genetic counseling services for City of Hope’s main campus, and her primary research interests are in hereditary GI cancer syndromes. In addition to patient care, she is passionate about education and is involved with the local genetic counseling programs and City of Hope's Intensive Course in Cancer Risk Assessment. She is a member of the National Society of Genetic Counselors, the Collaborative Group of the Americas on Inherited Gastrointestinal Cancers, the Southern California Genetic Counselors and the Minority Genetics Professionals Network.

Location

Education & Experience

Degrees
  • 2017, Master of Science in Genetic Counseling, Northwestern University, Chicago, IL
  • 2011, Bachelor of Science in Human Biology, Minor in Psychology, University of California San Diego, La Jolla, CA
Professional Experience
  • 2017-present, Cancer Risk Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA

Awards & Memberships

  • National Society of Genetic Counselors
  • Collaborative Group of the Americas on Inherited Colorectal Cancers
  • Southern California Genetic Counselors

Publications

  • Karuppuchamy T, Behrens E, González-Cabrera P, Sarkisyan G, Gima L, Boyer JD, Peach R. (2016). Sphingosine-1-phosphate receptor-1 (S1P1) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease. Mucosal immunology.
  • Karuppuchamy T, Behrens EH, González-Cabrera P, Sarkisyan G, Gima L, Boyer J, Peach R. (2016). 971a Inflammation Modulates the Sphingosine-1-Phosphate Pathway in Inflammatory Bowel Disease (IBD). Gastroenterology, 150(4), S195.
  • Dann SM, Manthey CF, Le C, Miyamoto Y, Gima L, Abrahim A, Cong Y. (2015). IL-17A promotes protective IgA responses and expression of other potential effectors against the lumen-dwelling enteric parasite Giardia. Experimental parasitology, 156, 68-78.
  • Veny M, Behrens E-H, Gima L, Rivera-Nieves J. Altered expression, desensitization and recycling of CCR9 in the TNFΔARE mouse model of Crohn’s disease. Poster Presentation. La Jolla Immunology Conference, San Diego, CA. October 2012.
  • Behrens E-H, Scott F, Clemons B, Veny M, Gima L, Gonzalez-Cabrera P, Peach R, Rivera-Nieves J. Sphingosine-1-phosphate pathway modulation; a novel therapeutic target for inflammatory bowel disease (IBD). Poster Presentation. La Jolla Immunology Conference, San Diego, CA. October 2012.